Inhibition of CXCL12 signaling attenuates the postischemic immune response and improves functional recovery after stroke

Journal of Cerebral Blood Flow and Metabolism

Volumn 33, Issue 8, 2013, Pages 1225-1234

  Ruscher, Karsten ^a   Kuric, Enida ^a   Liu, Yawei ^b   Walter, Helene L ^a   Issazadeh Navikas, Shohreh ^b   Englund, Elisabet ^c   Wieloch, Tadeusz ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

brain ischemia; chemokine; enriched environment; inflammation; regeneration and recovery; T cells

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; PLERIXAFOR; SODIUM CHLORIDE; STROMAL CELL DERIVED FACTOR 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATROPHY; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL DEATH; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CONVALESCENCE; HEMISPHERE; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; LYMPHOCYTIC INFILTRATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVOUS SYSTEM FUNCTION; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SPLEEN; SPLEEN CELL;

ANIMALS; ATROPHY; BLOTTING, WESTERN; BRAIN; BRAIN ISCHEMIA; CHEMOKINE CXCL12; DNA; DNA FRAGMENTATION; DOWN-REGULATION; ENVIRONMENT; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HETEROCYCLIC COMPOUNDS; IMMUNOHISTOCHEMISTRY; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE CEREBRAL ARTERY; RATS; RATS, INBRED SHR; RECEPTORS, CXCR4; RECOVERY OF FUNCTION; SIGNAL TRANSDUCTION; SPLEEN; STROKE;

EID: 84881121382     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2013.71     Document Type: Article

References (40)

1. Brewer L, Horgan F, Hickey A, Williams D. Stroke rehabilitation: recent advances and future therapies. QJM 2012; 106: 11-25.
2. Schlaug G, Marchina S, Wan CY. The use of non-invasive brain stimulation techniques to facilitate recovery from post-stroke aphasia. Neuropsychol Rev 2011; 21: 288-301.
3. Scheidtmann K, Fries W, Muller F, Koenig E. Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, double-blind study. Lancet 2001; 358: 787-790.
4. Bavelier D, Levi DM, Li RW, Dan Y, Hensch TK. Removing brakes on adult brain plasticity: from molecular to behavioral interventions. J Neurosci 2010; 30: 14964-14971.
5. Wieloch T, Nikolich K. Mechanisms of neural plasticity following brain injury. Curr Opin Neurobiol 2006; 16: 258-264.
6. Lalancette-Hebert M, Phaneuf D, Soucy G, Weng YC, Kriz J. Live imaging of Tolllike receptor 2 response in cerebral ischaemia reveals a role of olfactory bulb microglia as modulators of inflammation. Brain 2009; 132: 940-954.
7. Lucas SM, Rothwell NJ, Gibson RM. The role of inflammation in CNS injury and disease. Br J Pharmacol 2006; 147(Suppl 1): S232-S240.
8. Prass K, Meisel C, Hoflich C, Braun J, Halle E, Wolf T et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med 2003; 198: 725-736.
9. Offner H, Vandenbark AA, Hurn PD. Effect of experimental stroke on peripheral immunity: CNS ischemia induces profound immunosuppression. Neuroscience 2009; 158: 1098-1111.
10. Ajmo Jr CT, Collier LA, Leonardo CC, Hall AA, Green SM, Womble TA et al. Blockade of adrenoreceptors inhibits the splenic response to stroke. Exp Neurol 2009; 218: 47-55.
11. Lewitus GM, Schwartz M. Behavioral immunization: immunity to self-antigens contributes to psychological stress resilience. Mol Psychiatry 2009; 14: 532-536.
12. Williamson LL, Chao A, Bilbo SD. Environmental enrichment alters glial antigen expression and neuroimmune function in the adult rat hippocampus. Brain Behav Immun 2012; 26: 500-510.
13. Rickhag M, Deierborg T, Patel S, Ruscher K, Wieloch T. Apolipoprotein D is elevated in oligodendrocytes in the peri-infarct region after experimental stroke: influence of enriched environment. J Cereb Blood Flow Metab 2008; 28: 551-562.
14. Ruscher K, Johannesson E, Brugiere E, Erickson A, Rickhag M, Wieloch T. Enriched environment reduces apolipoprotein E (ApoE) in reactive astrocytes and attenuates inflammation of the peri-infarct tissue after experimental stroke. J Cereb Blood Flow Metab 2009; 29: 1796-1805.
15. Ruscher K, Shamloo M, Rickhag M, Ladunga I, Soriano L, Gisselsson L et al. The sigma-1 receptor enhances brain plasticity and functional recovery after experimental stroke. Brain 2011; 134: 732-746.
16. Johansson BB, Belichenko PV. Neuronal plasticity and dendritic spines: effect of environmental enrichment on intact and postischemic rat brain. J Cereb Blood Flow Metab 2002; 22: 89-96.
17. Nygren J, Wieloch T, Pesic J, Brundin P, Deierborg T. Enriched environment attenuates cell genesis in subventricular zone after focal ischemia in mice and decreases migration of newborn cells to the striatum. Stroke 2006; 37: 2824-2829.
18. Endres M, Engelhardt B, Koistinaho J, Lindvall O, Meairs S, Mohr JP et al. Improving outcome after stroke: overcoming the translational roadblock. Cerebrovasc Dis 2008; 25: 268-278.
19. Thelen M, Thelen S. CXCR7, CXCR4 and CXCL12: an eccentric trio? J Neuroimmunol 2008; 198: 9-13.
20. Zhu Y, Murakami F. Chemokine CXCL12 and its receptors in the developing central nervous system: emerging themes and future perspectives. Dev Neurobiol 2012; 72: 1349-1362.
21. Marchionni I, Takács VT, Nunzi MG, Mugnaini E, Miller RJ, Maccaferri G. Distinctive properties of CXC chemokine receptor 4-expressing Cajal-Retzius cells versus GABAergic interneurons of the postnatal hippocampus. J Physiol 2010; 588: 2859-2878.
22. Adler MW, Geller EB, Chen X, Rogers TJ. Viewing chemokines as a third major system of communication in the brain. AAPS J 2005; 7: E865-E870.
23. Ohab JJ, Fleming S, Blesch A, Carmichael ST. A neurovascular niche for neurogenesis after stroke. J Neurosci 2006; 26: 13007-13016.
24. Hill WD, Hess DC, Martin-Studdard A, Carothers JJ, Zheng J, Hale D et al. SDF-1 (CXCL12) is upregulated in the ischemic penumbra following stroke: association with bone marrow cell homing to injury. J Neuropathol Exp Neurol 2004; 63: 84-96.
25. Schonemeier B, Schulz S, Hoellt V, Stumm R. Enhanced expression of the CXCl12/SDF-1 chemokine receptor CXCR7 after cerebral ischemia in the rat brain. J Neuroimmunol 2008; 198: 39-45.
26. Blades MC, Ingegnoli F, Wheller SK, Manzo A, Wahid S, Panayi GS et al. Stromal cell-derived factor 1 (CXCL12) induces monocyte migration into human synovium transplanted onto SCID Mice. Arthritis Rheum 2002; 46: 824-836.
27. Meiron M, Zohar Y, Anunu R, Wildbaum G, Karin N. CXCL12 (SDF-1alpha) suppresses ongoing experimental autoimmune encephalomyelitis by selecting antigen-specific regulatory T cells. J Exp Med 2008; 205: 2643-2655.
28. McCandless EE, Zhang B, Diamond MS, Klein RS. CXCR4 antagonism increases T cell trafficking in the central nervous system and improves survival from West Nile virus encephalitis. Proc Natl Acad Sci USA 2008; 105: 11270-11275.
29. Liles WC, Broxmeyer HE, Rodger E, Wood B, Hubel K, Cooper S et al. Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. Blood 2003; 102: 2728-2730.
30. del Zoppo GJ. Acute anti-inflammatory approaches to ischemic stroke. Ann N Y Acad Sci 2010; 1207: 143-148.
31. Vexler ZS, Yenari MA. Does inflammation after stroke affect the developing brain differently than adult brain? Dev Neurosci 2009; 31: 378-393.
32. Stevens SL, Bao J, Hollis J, Lessov NS, Clark WM, Stenzel-Poore MP. The use of flow cytometry to evaluate temporal changes in inflammatory cells following focal cerebral ischemia in mice. Brain Res 2002; 932: 110-119.
33. Lewitus GM, Zhu J, Xiong H, Hallworth R, Kipnis J. CD4(\+), CD25(-) effector T-cells inhibit hippocampal long-term potentiation in vitro. Eur J Neurosci 2007; 26: 1399-1406.
34. Ren X, Akiyoshi K, Dziennis S, Vandenbark AA, Herson PS, Hurn PD et al. Regulatory B cells limit CNS inflammation and neurologic deficits in murine experimental stroke. J Neurosci 2011; 31: 8556-8563.
35. Huang J, Li Y, Tang Y, Tang G, Yang GY, Wang Y. CXCR4 antagonist AMD3100 protects blood-brain barrier integrity and reduces inflammatory response after focal ischemia in mice. Stroke 2012; 44: 190-197.
36. Seifert HA, Hall AA, Chapman CB, Collier LA, Willing AE, Pennypacker KR. A transient decrease in spleen size following stroke corresponds to splenocyte release into systemic circulation. J Neuroimmune Pharmacol 2012; 7: 1017-1024.
37. Bezzi P, Domercq M, Brambilla L, Galli R, Schols D, De Clercq E et al. CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat Neurosci 2001; 4: 702-710.
38. Fan Y, Shen F, Frenzel T, Zhu W, Ye J, Liu J et al. Endothelial progenitor cell transplantation improves long-term stroke outcome in mice. Ann Neurol 2010; 67: 488-497.
39. Bhattacharyya BJ, Banisadr G, Jung H, Ren D, Cronshaw DG, Zou Y et al. The chemokine stromal cell-derived factor-1 regulates GABAergic inputs to neural progenitors in the postnatal dentate gyrus. J Neurosci 2008; 28: 6720-6730.
40. Patel JR, McCandless EE, Dorsey D, Klein RS. CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelination. Proc Natl Acad Sci USA 2010; 107: 11062-11067.